How Changes To 'Dear Doctor Letters' Will Impact Industry

Law360, New York (March 31, 2014, 5:59 PM EDT) -- The U.S. Food and Drug Administration's guidance on "Dear Health Care Provider" ("DHCP") letters, finalized earlier this year, provides further clarity on the agency's expectations for the content, format and use of the communications that manufacturers issue to convey important, newly-discovered safety and other information on drugs and biologics....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!